| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/10/2008 | US20080167370 Multidrug multiligand conjugates for targeted drug delivery |
| 07/10/2008 | US20080166299 Prevent accumulation of amyloid deposits |
| 07/10/2008 | US20080166298 6- (2, 3, 4, 5-Tetrahydro-1H-Benzo [D] Azepin-7-Yloxy) -Nicotamide Derivatives as Radio Labelled Ligands |
| 07/10/2008 | US20080166297 Radionuclide-Chitosan Complex Having an Improved Stablilized Gelatin in Administering Them to the Body and Their Preparation Method |
| 07/10/2008 | US20080166296 Pharmaceutical Gallium Compositions and Methods |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 07/10/2008 | US20080166292 Pharmaceutical Dosing Method |
| 07/10/2008 | CA2674466A1 Compounds and methods for detection of cells |
| 07/10/2008 | CA2673853A1 Ligands for imaging cardiac innervation |
| 07/09/2008 | EP1940475A2 Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging |
| 07/09/2008 | EP1753417A4 Selective androgen receptor modulators and methods of use thereof |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | CN101217983A Improved process for the production of a radioactive aerosol |
| 07/09/2008 | CN101214382A Method for preparing europium-labeled hydroxyapatite nano particle |
| 07/09/2008 | CN101214376A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 07/09/2008 | CN100400107C Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease |
| 07/09/2008 | CN100400106C Tween induced technetium-99m isonitrile complex, two-stage isonitrile medicinal box and its use |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396814 Metallopeptide compositions for treatment of sexual dysfunction |
| 07/08/2008 | US7396523 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 07/08/2008 | CA2505506C Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 07/08/2008 | CA2253154C Process for the manufacture of amorphous products by means of convection drying |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/03/2008 | WO2008079361A2 Cxcl13 binding proteins |
| 07/03/2008 | WO2008078589A1 Process for production of precursor compound for radioactive halogen-labeled organic compound |
| 07/03/2008 | WO2008024188A8 Dual variable domain immunoglobulin and uses thereof |
| 07/03/2008 | WO2008011173A3 Improvement of arginase levels/activity |
| 07/03/2008 | US20080161537 Selective radiolabeling of biomolecules |
| 07/03/2008 | US20080160504 Swallowing labelled substrate and monitoring incorporation of label in CO2, using variation in incorporation as evaluative tool in diagnosing/prognosing gastrointestinal disorders |
| 07/03/2008 | US20080160098 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160092 Use of simple amino acids to form porous particles |
| 07/03/2008 | CA2672914A1 Process for production of precursor compound for radioactive halogen-labeled organic compound |
| 07/02/2008 | EP1937317A2 Automated method for preparing technetium complexes |
| 07/02/2008 | EP1937316A2 Radioprotective agents |
| 07/02/2008 | EP1937260A2 In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 07/02/2008 | EP1824473A4 Radioactive chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method |
| 07/02/2008 | EP1572747B1 Tumor-specific recognition molecules |
| 07/02/2008 | EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment |
| 07/02/2008 | CN101210016A Heterocycle-fused morphinans compounds, preparation method and use thereof |
| 07/01/2008 | US7394081 Radioisotope production apparatus and radiopharmaceutical production apparatus |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 06/26/2008 | WO2008075966A2 Synthesis of a radiofluorinated peptide using photolabile protecting groups |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008075040A2 Radioactive pet agents for imaging ccr5 in vivo |
| 06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
| 06/26/2008 | WO2008074960A2 New conjugates for therapeutic purposes and/or as diagnosis and/or imaging agents and method for preparing the same |
| 06/26/2008 | WO2008074804A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/26/2008 | WO2008030604A3 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 06/26/2008 | US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole |
| 06/26/2008 | US20080153865 Water soluble paclitaxel derivatives |
| 06/26/2008 | US20080152588 Metal Chelators and Methods of Their Use |
| 06/26/2008 | US20080152587 TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF |
| 06/26/2008 | US20080152586 Protein complexes comprising three or more polypeptides, each having multiple immunoglobulin like domains, which associate to form target binding regions, for use as therapeutic, diagnostic or imaging agents |
| 06/26/2008 | US20080152585 comprising a mixture of drugs having nanostructure particle sizes, surfactants and excipients or carriers |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2672810A1 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1934234A2 Novel amine-borane compounds and uses thereof |
| 06/25/2008 | EP1934160A1 Method for the use of [11c]carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation |
| 06/25/2008 | EP1933885A2 Automated radiolabelling method |
| 06/25/2008 | EP1933714A2 Systems, compositions, and methods for local imaging and treatment of pain |
| 06/25/2008 | CN101208109A Method and apparatus for kidney function analysis |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390902 N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-iodo-benzamide; high affinity and high selectivity for sigma 2 receptors; Bromine, Iodine, Carbon, Tritium radioisitops; PET and SPECT; breast cancer |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390828 Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents |
| 06/24/2008 | US7390635 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy |
| 06/19/2008 | WO2008073458A2 Fibrin-binding peptides and conjugates thereof |
| 06/19/2008 | WO2008072976A2 Synthesis of a radiofluorinated peptide using microwave activation technology |
| 06/19/2008 | WO2008072973A2 Radiolabelled peptide based compounds and uses thereof |
| 06/19/2008 | WO2008023251A3 Radiolabeled 1-acetate pet imaging for radiotherapy in head and neck cancer |
| 06/19/2008 | WO2007148088A3 Radiopharmaceutical products |
| 06/19/2008 | US20080147166 Coated implantable medical device |
| 06/19/2008 | US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 06/19/2008 | US20080145399 coronary stent has a multilayer coatings for controlled release of immunosuppressive agent active materials, including a porous cover layer |
| 06/19/2008 | US20080145398 Coated implantable medical device |
| 06/19/2008 | US20080145396 Coated implantable medical device |
| 06/19/2008 | US20080145394 Coated implantable medical device |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145311 Chelating agents with lipophilic carriers |
| 06/19/2008 | DE102006058542A1 Säulensystem zur Herstellung einer Lösung mit hoher spezifischer Aktivität Column system for preparing a solution of high specific activity |
| 06/19/2008 | CA2671564A1 Radiolabelled peptide based compounds and uses thereof |
| 06/18/2008 | EP1931673A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 06/18/2008 | CN101203249A Poly(peptide) as a chelator: methods of manufacture and uses |
| 06/18/2008 | CN101200448A Beta-elemene derivatives as well as Re complex and 188Re marker thereof |
| 06/17/2008 | US7387772 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer |
| 06/17/2008 | US7387771 dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide |
| 06/17/2008 | CA2284732C Analogs of cocaine |
| 06/17/2008 | CA2189051C Composition for delivery of toxic radioisotopes to the cell nucleus and use |
| 06/12/2008 | WO2008070464A2 Methods of imaging employing chelating agents |
| 06/12/2008 | WO2008070384A2 Method of preparing macromolecular contrast agents and uses thereof |
| 06/12/2008 | WO2008070336A2 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 06/12/2008 | WO2008070291A2 Improved linkers for anchoring targeting ligands |
| 06/12/2008 | WO2008068974A1 Aurone derivative-containing composition for diagnosis |
| 06/12/2008 | WO2008017944A3 Composition apparatus and method for use in imaging |
| 06/12/2008 | WO2008011496A3 Method for radiolabeling formulations for gamma scintigraphy assesment |
| 06/12/2008 | US20080138899 Destroying cell expressing polypeptide of given sequence by contacting with cytotoxic immunoconjugate; ricin, doxorubicin; treatment and detection of prostate cancer metastasis |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |